BerandaBMRN • NASDAQ
add
Biomarin Pharmaceutical Inc
Tutup sebelumnya
$52,52
Rentang hari
$51,86 - $52,76
Rentang tahun
$51,02 - $73,51
Kapitalisasi pasar
10,03 M USD
Volume Rata-Rata
2,56 jt
Rasio P/E
19,60
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 776,13 jt | 4,08% |
Biaya operasional | 682,74 jt | 53,98% |
Penghasilan bersih | -30,74 jt | -128,98% |
Margin laba bersih | -3,96 | -127,85% |
Penghasilan per saham | 0,12 | -86,81% |
EBITDA | -28,20 jt | -121,22% |
Tarif pajak efektif | -16,79% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,48 M | 58,83% |
Total aset | 7,61 M | 11,15% |
Total liabilitas | 1,56 M | 8,37% |
Total ekuitas | 6,06 M | — |
Saham yang beredar | 192,11 jt | — |
Harga terhadap nilai buku | 1,67 | — |
Tingkat pengembalian aset | -1,55% | — |
Tingkat pengembalian modal | -1,76% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -30,74 jt | -128,98% |
Kas dari operasi | 368,68 jt | 66,46% |
Kas dari investasi | -330,96 jt | -1.948,42% |
Kas dari pembiayaan | -2,17 jt | 99,57% |
Perubahan kas bersih | 36,29 jt | 112,23% |
Arus kas bebas | 114,03 jt | -31,13% |
Tentang
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria.
Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials. Wikipedia
Didirikan
Mar 1997
Kantor pusat
Situs
Karyawan
3.040
